TEDCO — 2018 Investments

2 investments dated 2018 · listed companies and verified rows first · show all

KaloCytekalocyte.com inApr 2018

KaloCyte develops ErythroMer, a dried, shelf-stable artificial red blood cell for use in emergency and trauma care when stored blood is unavailable or in short supply.

BiotechDeep TechHealthtechMedical DevicesBaltimore, US

Allan Doctor(Co-Founder & CSO)in Dipanjan Pan(Co-Founder, Chief Technical Officer)in Philip Spinella(Co-Founder, Chief Medical Officer)inDaniel Getman(Director)Gregory Lanza(Director)

Co-investorsBioAdvance BioGenerator Ventures Delaware Crossing Investor Group Maryland TEDCO NYBC Ventures Old Line Capital Partners +1 more

Lifesproutbiolifesproutbio.comFeb 2018

LifeSprout develops synthetic materials that mimic the body's own tissues for aesthetic and regenerative medicine, creating products to treat patients with soft tissue loss from aging, cancer, and metabolic disease.

BiotechMedical DevicesNew MaterialsBaltimore, US

Hai-Quan Mao(Co-founder, PhD)Sashank Reddy(Co-founder, MD, PhD)Kevin Colbert(Co-founder, Business Development)inRuss Martin(Co-founder, Head of R&D, PhD)inAdam Gridley(Executive Chairman, MBA)

Co-investorsCatalio Capital Management, LP Emerald Development Managers Maryland TEDCO

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.